Inhibitory effect of carboxylic acid group on hERG binding
Authors:
- Bing-Yan ZhuBZBing-Yan Zhu
- Yonghong SongYSYonghong Song
- 1 November 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (21) , 5507-5512
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approachesBioorganic & Medicinal Chemistry Letters, 2003
- K+ Channel Structure-Activity Relationships and Mechanisms of Drug-Induced QT ProlongationAnnual Review of Pharmacology and Toxicology, 2003
- Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug developmentCardiovascular Research, 2003
- The Relationship of Clinical QT Prolongation to Outcome in the Conscious Dog Using a Beat-to-Beat QT-RR Interval AssessmentThe Journal of Pharmacology and Experimental Therapeutics, 2002
- [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screenEuropean Journal of Pharmacology, 2001
- Molecular and Cellular Mechanisms of Cardiac ArrhythmiasCell, 2001
- Screening lead compounds for QT interval prolongationDrug Discovery Today, 2001
- A structural basis for drug-induced long QT syndromeProceedings of the National Academy of Sciences, 2000
- The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications Report on a Policy Conference of the European Society of CardiologyCardiovascular Research, 2000
- Blocker protection in the pore of a voltage-gated K+ channel and its structural implicationsNature, 2000